Vaccination Practices for Inflammatory Bowel Disease Patients in China With Gastroenterologists
Insufficient Awareness and Vaccination Practices for Inflammatory Bowel Disease Patients in China: A Multi-center Survey of Chinese Gastroenterologists
1 other identifier
observational
307
1 country
1
Brief Summary
The aim of the current study was to evaluate the knowledge of Chinese gastroenterologists on vaccinating patients with IBD under the assistance of Chinese Crohn's \& Colitis Foundation. The Chinese Crohn's \& Colitis Foundation (CCCF) is the first nonprofit,volunteer-driven foundation specifically for patients with IBD in China.It has been joined by IBD specialists at various hospitals in China.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedFirst Submitted
Initial submission to the registry
June 17, 2021
CompletedFirst Posted
Study publicly available on registry
July 2, 2021
CompletedJuly 19, 2021
July 1, 2021
Same day
June 17, 2021
July 13, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
vaccination practices
The questionnaire mainly contained three sections: knowledge of vaccinations for hepatitis A virus (HAV), HBV, and varicella; current vaccination practices for the IBD group; and reasons for not recommending these vaccinations to patients with IBD. The questionnaire captured the frequency with which the respondents assessed patients with IBD for anti-HAV/hepatitis B surface antigen (HBsAg), hepatitis B core antibody, and hepatitis B surface antibody/ anti-HAV levels, and acquired infection and immunization histories.
between July 2017 and August 2017
Eligibility Criteria
An email with a quick response code (QRC) was sent to CCCF-affiliated gastroenterologists specializing in IBD between July 2017 and August 2017
You may qualify if:
- gastroenterologists were members of tertiary hospitals
You may not qualify if:
- pediatricians were excluded, as were retired gastroenterologists and those currently in training
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Second Affiliated Hospital, School of Medicine, Zhejiang Universitylead
- Sixth Affiliated Hospital, Sun Yat-sen Universitycollaborator
- Ruijin Hospitalcollaborator
- Zhujiang Hospitalcollaborator
- Army Medical University, Chinacollaborator
- Peking Union Medical College Hospitalcollaborator
- The First Affiliated Hospital of Zhejiang Chinese Medical Universitycollaborator
- Affiliated Hospital of Nanjing University of Chinese Medicinecollaborator
- Lishui Municipal Central Hospital, the Fifth Affiliated Hospital of Wenzhou Medical Universitycollaborator
- Shaoxing Shangyu People's Hospitalcollaborator
Study Sites (1)
Shuyan Li
Zhejiang, Hangzhou, 310009, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Yan Chen
2ndAffiliated Hospital, School of Medicine, Zhejiang University, China
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 17, 2021
First Posted
July 2, 2021
Study Start
July 1, 2017
Primary Completion
July 1, 2017
Study Completion
August 1, 2017
Last Updated
July 19, 2021
Record last verified: 2021-07